Showing 38,141 - 38,160 results of 100,237 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( 5 ((nm decrease) OR (teer decrease)) ))', query time: 1.70s Refine Results
  1. 38141
  2. 38142
  3. 38143
  4. 38144

    Image_2_Personalized dietary advices provided by a dietitian increase calcium intake in outpatients with multiple sclerosis—Results from a randomized, controlled, single-blind tria... by Sandrine Fiorella (14434197)

    Published 2023
    “…Background and aims<p>Multiple sclerosis (MS) is associated with osteoporosis, possibly due to neurological disability and decreased calcium intake. The objective of this study was to evaluate the efficacy of a personalized nutritional advice program by a dietitian compared to the delivery of a standard advice form to optimize dietary calcium intake in outpatients with MS.…”
  5. 38145

    Image_1_Personalized dietary advices provided by a dietitian increase calcium intake in outpatients with multiple sclerosis—Results from a randomized, controlled, single-blind tria... by Sandrine Fiorella (14434197)

    Published 2023
    “…Background and aims<p>Multiple sclerosis (MS) is associated with osteoporosis, possibly due to neurological disability and decreased calcium intake. The objective of this study was to evaluate the efficacy of a personalized nutritional advice program by a dietitian compared to the delivery of a standard advice form to optimize dietary calcium intake in outpatients with MS.…”
  6. 38146
  7. 38147
  8. 38148
  9. 38149
  10. 38150

    Thermodynamic parameters. by Jianqing Jia (21001506)

    Published 2025
    “…Consequently, tunnel reliability decreases. Specifically, with temperature increases of 2.6 °C and 4 °C, tunnel reliability decreases by approximately 4.5% and 6.3%, respectively, when considering insulation layer deterioration.…”
  11. 38151
  12. 38152

    Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy by Leila Bertoni Giron (6848399)

    Published 2019
    “…Lower antibody and LPS levels among patients with initial PI-r ART suggest these regimens may more effectively suppress HIV and have a higher capacity to decrease the HIV antigenic component.…”
  13. 38153
  14. 38154

    Stability and C–H Bond Activation Reactions of Palladium(I) and Platinum(I) Metalloradicals: Carbon-to-Metal H‑Atom Transfer and an Organometallic Radical Rebound Mechanism by Tobias Krämer (1350849)

    Published 2023
    “…One-electron oxidation of palladium(0) and platinum(0) bis(phosphine) complexes enables isolation of a homologous series of linear d<sup>9</sup> metalloradicals of the form [M(PR<sub>3</sub>)<sub>2</sub>]<sup>+</sup> (M = Pd, Pt; R = <i>t</i>Bu, Ad), which are stable in 1,2-difluorobenzene (DFB) solution for >1 day at room temperature when partnered with the weakly coordinating [BAr<sup>F</sup><sub>4</sub>]<sup>−</sup> (Ar<sup>F</sup> = 3,5-(CF<sub>3</sub>)<sub>2</sub>C<sub>6</sub>H<sub>3</sub>) counterion. …”
  15. 38155

    Stability and C–H Bond Activation Reactions of Palladium(I) and Platinum(I) Metalloradicals: Carbon-to-Metal H‑Atom Transfer and an Organometallic Radical Rebound Mechanism by Tobias Krämer (1350849)

    Published 2023
    “…One-electron oxidation of palladium(0) and platinum(0) bis(phosphine) complexes enables isolation of a homologous series of linear d<sup>9</sup> metalloradicals of the form [M(PR<sub>3</sub>)<sub>2</sub>]<sup>+</sup> (M = Pd, Pt; R = <i>t</i>Bu, Ad), which are stable in 1,2-difluorobenzene (DFB) solution for >1 day at room temperature when partnered with the weakly coordinating [BAr<sup>F</sup><sub>4</sub>]<sup>−</sup> (Ar<sup>F</sup> = 3,5-(CF<sub>3</sub>)<sub>2</sub>C<sub>6</sub>H<sub>3</sub>) counterion. …”
  16. 38156

    Distribution of the ΔNPP-to-ΔMAT ratio in relation to MAT and MAP under the current climate. by Jumpei Toriyama (10156884)

    Published 2021
    “…<p>Results from (A) MIROC5 and (B) GFDL-CM3, based on the RCP2.6 scenario. …”
  17. 38157
  18. 38158
  19. 38159

    Image_2_A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.tif by James J. Harding (12415627)

    Published 2022
    “…Adult patients with treatment-refractory solid tumors received PF-06671008 (1.5–400 ng/kg) as a weekly intravenous (IV) infusion on a 21-day/3-week cycle. …”
  20. 38160

    Image_1_A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.tif by James J. Harding (12415627)

    Published 2022
    “…Adult patients with treatment-refractory solid tumors received PF-06671008 (1.5–400 ng/kg) as a weekly intravenous (IV) infusion on a 21-day/3-week cycle. …”